Cambridge, MA

Client Opportunity

Epizyme Inc. is a late-stage biopharmaceutical company committed to rewriting treatment for cancer and other serious diseases through novel epigenetic medicines. Epizyme is developing its lead product candidate, tazemetostat, an oral, first-in-class EZH2 inhibitor. Studies are underway in solid tumors and hematological malignancies as a monotherapy and combination therapy in relapsed and front-line disease.

They partnered with The Bowdoin Group to help with their VP of Marketing hire. This client’s goal was to engage with a candidate with strong strategic marketing skills and product launch experience aligned with the company’s mission.

The perfect candidate:

  • Experience creating and executing the strategic vision and go-to-market strategy for an earlier stage commercial organization
  • 15+ years of pharmaceutical marketing experience, preferably in U.S. oncology/hematology, specifically lymphoma
  • Demonstrates connectedness, humor, and mutual respect
  •  Exhibits a risk-tolerant, creative approach to solving problems, is genuinely curious, and able to raise the bar
  •  Exhibits passion for candidates and a sense of urgency to help patients through a shared purpose
  • Ability to be agile, optimistic, adaptable, evolutionary, and embrace change

The TBG Process

  • Build lists of oncology and hematology focused companies in the Boston Area
  • Utilize The Bowdoin Group’s network within the Life Sciences space in the Boston Area

  • Services:
    • Executive Search
  • Placements:
    • VP of Marketing
  • Employee Count:
    • 100-500
  • Funding Rounds:
    • Publicly Traded

Client Result

As a result, the team welcomed their new VP of Marketing in June 2020.